Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation
Program in Molecular Medicine
Biochemistry | Cell Biology | Cellular and Molecular Physiology | Molecular Biology
Glycogen synthase kinase 3beta (GSK3beta) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3beta activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3beta by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3beta substrate beta-catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3beta by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of beta-catenin. p38 MAPK-mediated phosphorylation of GSK3beta occurs primarily in the brain and thymocytes. Activation of beta-catenin-mediated signaling through GSK3beta inhibition provides a potential mechanism for p38 MAPK-mediated survival in specific tissues.
Rights and Permissions
Citation: Science. 2008 May 2;320(5876):667-70. doi: 10.1126/science.1156037. Link to article on publisher's site
Thornton, Tina; Pedraza-Alva, Gustavo; Deng, Bin; Wood, C. David; Aronshtam, Alexander; Clements, James L.; Sabio, Guadalupe; Davis, Roger J.; Matthews, Dwight E.; Doble, Bradley; and Rincon, Mercedes, "Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation" (2008). Davis Lab. 68.